Pfizer Inc. Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit

NEW YORK--(BUSINESS WIRE)--Pfizer announced today that it has named Mace L. Rothenberg, M.D. as Senior Vice President, Clinical Development and Medical Affairs for its Oncology Business Unit. Dr. Rothenberg comes to Pfizer from Vanderbilt where he was Professor of Medicine at the Vanderbilt University Medical Center and Ingram Professor of Cancer Research at the Vanderbilt-Ingram Cancer Center.
MORE ON THIS TOPIC